Ghost Tree Capital, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 88 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.5%.

Quarter-by-quarter ownership
Ghost Tree Capital, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,044,550
+305.6%
295,000
+293.3%
1.99%
+304.1%
Q2 2023$1,490,250
-53.0%
75,000
-62.5%
0.49%
-28.5%
Q1 2022$3,172,000
-65.8%
200,000
-52.9%
0.69%
-79.3%
Q4 2021$9,278,000
-11.3%
425,000
+21.4%
3.32%
+8.7%
Q3 2021$10,462,000
+89.0%
350,000
+180.0%
3.06%
+101.0%
Q2 2021$5,536,000
-61.6%
125,000
-61.5%
1.52%
-55.1%
Q1 2021$14,420,000
-47.4%
325,000
-35.0%
3.39%
-44.5%
Q4 2020$27,420,000
+199.9%
500,000
+25.0%
6.11%
+131.2%
Q3 2020$9,144,000
-32.8%
400,000
-38.5%
2.64%
-26.4%
Q2 2020$13,605,000
+50.0%
650,0000.0%3.59%
+49.2%
Q1 2020$9,068,000
-43.1%
650,000
-7.1%
2.40%
-20.7%
Q4 2019$15,932,000
+118.8%
700,000
+12.0%
3.03%
+63.6%
Q3 2019$7,281,000
+5.5%
625,000
+35.9%
1.86%
+29.6%
Q2 2019$6,900,000
-34.4%
460,000
-23.3%
1.43%
-48.0%
Q1 2019$10,524,000
+18.4%
600,0000.0%2.75%
-14.8%
Q4 2018$8,892,000
-9.7%
600,000
+50.0%
3.23%
+54.2%
Q3 2018$9,848,000
+43.3%
400,000
+14.3%
2.09%
+3.5%
Q2 2018$6,871,000
-56.9%
350,000
-58.8%
2.02%
-37.3%
Q1 2018$15,938,000850,0003.22%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders